Affymetrix's Q4 Revenues Rise 10 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Affymetrix reported after the close of the market Wednesday that its fourth quarter revenues climbed around 10 percent year over year, as sales growth for its consumables products and eBioscience business more than offset a decline in instrument revenue.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.